Qingdao Vland Biotech Co Ltd (603739) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.013x

Based on the latest financial reports, Qingdao Vland Biotech Co Ltd (603739) has a cash flow conversion efficiency ratio of 0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥24.29 Million ≈ $3.55 Million USD) by net assets (CN¥1.90 Billion ≈ $278.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 603739 market cap overview for the company's overall valuation and market capitalisation.

Qingdao Vland Biotech Co Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Qingdao Vland Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Qingdao Vland Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Qingdao Vland Biotech Co Ltd ranked by their cash flow conversion efficiency. Explore Qingdao Vland Biotech Co Ltd cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Stabilus S.A. XETRA:STM	0.008x
Nueva Expresión Textil S.A. MC:NXT	-0.017x
AS Tallink Grupp HE:TALLINK	0.020x
Miller Industries Inc NYSE:MLR	0.047x
Apogee Optocom Co Ltd TW:6426	0.021x
Altia Consultores S.A. MC:ALC	0.169x
Djurslands Bank CO:DJUR	0.002x
QUADIENT SA ADR1/15/EO 1 F:NEQ0	N/A

Annual Cash Flow Conversion Efficiency for Qingdao Vland Biotech Co Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of Qingdao Vland Biotech Co Ltd from 2014 to 2024. View 603739 live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.87 Billion ≈ $273.64 Million	CN¥195.41 Million ≈ $28.59 Million	0.104x	+24.19%
2023-12-31	CN¥1.83 Billion ≈ $267.11 Million	CN¥153.59 Million ≈ $22.48 Million	0.084x	+53.08%
2022-12-31	CN¥1.73 Billion ≈ $253.73 Million	CN¥95.31 Million ≈ $13.95 Million	0.055x	+3.50%
2021-12-31	CN¥1.69 Billion ≈ $246.65 Million	CN¥89.51 Million ≈ $13.10 Million	0.053x	-65.76%
2020-12-31	CN¥1.12 Billion ≈ $163.20 Million	CN¥173.00 Million ≈ $25.31 Million	0.155x	+145.11%
2019-12-31	CN¥1.03 Billion ≈ $151.05 Million	CN¥65.33 Million ≈ $9.56 Million	0.063x	-53.40%
2018-12-31	CN¥631.38 Million ≈ $92.39 Million	CN¥85.75 Million ≈ $12.55 Million	0.136x	-33.98%
2017-12-31	CN¥592.53 Million ≈ $86.71 Million	CN¥121.90 Million ≈ $17.84 Million	0.206x	-25.70%
2016-12-31	CN¥557.97 Million ≈ $81.65 Million	CN¥154.49 Million ≈ $22.61 Million	0.277x	+93.62%
2015-12-31	CN¥519.36 Million ≈ $76.00 Million	CN¥74.27 Million ≈ $10.87 Million	0.143x	+13.88%
2014-12-31	CN¥466.26 Million ≈ $68.23 Million	CN¥58.55 Million ≈ $8.57 Million	0.126x	--

About Qingdao Vland Biotech Co Ltd

SHG:603739 China Biotechnology

Market Cap

$453.20 Million

CN¥3.10 Billion CNY

Market Cap Rank

#12872 Global

#3813 in China

Share Price

CN¥12.24

Change (1 day)

-0.16%

52-Week Range

CN¥10.81 - CN¥16.74

All Time High

CN¥58.91